Edgardo Baracchini Jr's Net Worth
$5.35 Million
Who is Edgardo Baracchini Jr?
Edgardo Baracchini Jr has an estimated net worth of $5.35 Million. This is based on reported shares across multiple companies, which include Xencor Inc, Inmune Bio, Inc., and METABASIS THERAPEUTICS INC.
SEC CIK
Edgardo Baracchini Jr's CIK is 0001291972
Past Insider Trading and Trends
2015 was Edgardo Baracchini Jr's most active year for acquiring shares with 8 total transactions. Edgardo Baracchini Jr's most active month to acquire stocks was the month of February. 2015 was Edgardo Baracchini Jr's most active year for disposing of shares, totalling 18 transactions. Edgardo Baracchini Jr's most active month to dispose stocks was the month of July. 2018 saw Edgardo Baracchini Jr paying a total of $604,460.71 for 194,069 shares, this is the most they've acquired in one year. In 2018 Edgardo Baracchini Jr cashed out on 276,138 shares for a total of $4,638,309.11, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Xencor Inc (XNCR) Snapshot price: $16.18
Chief Business Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
$25.60 | -$1,455,617.12 | 207 |
Aug 9 - Aug 13
| |||
Form 4
|
—
|
0
|
$15.74 | -$1,212,144.00 |
0
|
Mar 15
| |||
Form 4
|
—
|
0
|
$15.09 | -$580,006.00 |
0
|
Scheduled
|
Mar 2 - Mar 5
| ||
Form 4
|
—
|
0
|
$15.12 | -$581,048.00 |
0
|
Scheduled
|
Feb 27
| ||
Form 4
|
—
|
0
|
$13.30 | -$205,033.29 |
0
|
Scheduled
|
Feb 22
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 24
| |||
Form 4
|
—
|
0
|
$13.30 | -$268,682.06 |
0
|
May 1 - May 2
| |||
Form 4
|
—
|
0
|
$13.32 | -$23,006.71 |
0
|
Apr 27
| |||
Form 4
|
—
|
0
|
$12.80 | -$44,450.61 |
0
|
Mar 8
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 30
| |||
Form 4
|
—
|
0
|
$12.97 | -$247,574.89 |
0
|
Scheduled
|
Sep 28
| ||
Form 4
|
—
|
0
|
$10.83 | -$204,741.00 |
0
|
Sep 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 21
| |||
Form 4
|
—
|
0
|
$11.21 | -$53,100.75 |
0
|
Scheduled
|
Aug 10
| ||
Form 4
| -100.00% | -4.53K |
$20.00 | -$90,560.00 |
0
|
Scheduled
|
Aug 3
| ||
Form 4
|
—
|
0
|
$9.36 | -$21,925.00 | 4.53K |
Scheduled
|
Jul 11
| ||
Form 4
|
—
|
0
|
$7.85 | -$18,137.50 | 4.53K |
Scheduled
|
Jun 28
| ||
Form 4
|
—
|
0
|
$7.80 | -$54,037.50 | 4.53K |
Scheduled
|
Apr 7
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 26
| |||
Form 4
|
∞
| 4.53K |
—
|
—
| 4.53K |
Dec 15
| |||
Form 4
|
—
|
0
|
$8.26 | -$19,171.00 |
0
|
Scheduled
|
Dec 1
| ||
Form 4
|
—
|
0
|
$7.80 | -$36,025.00 |
0
|
Scheduled
|
Nov 25
| ||
Form 4
|
—
|
0
|
$8.54 | -$19,875.00 |
0
|
Scheduled
|
Sep 1
| ||
Form 4
|
—
|
0
|
$11.23 | -$53,174.00 |
0
|
Scheduled
|
Aug 3
| ||
Form 4
|
—
|
0
|
$11.42 | -$54,116.50 |
0
|
Scheduled
|
Jul 1
| ||
Form 4/A
| -100.00% | -1.28K |
$19.85 | -$25,348.71 |
0
|
Scheduled
|
Jun 15
| ||
Form 4
| -100.00% | -1.28K |
$19.85 | -$25,348.71 |
0
|
Scheduled
|
Jun 15
| ||
Form 4
|
—
|
0
|
$9.37 | -$21,937.50 |
0
|
Scheduled
|
Jun 1
| ||
Form 4
| -100.00% | -1.60K |
$15.00 | -$24,060.00 |
0
|
Scheduled
|
May 15
| ||
Form 4
| -11.09% | -200.00 |
$15.00 | -$3,000.00 | 1.6K |
Scheduled
|
May 13
| ||
Form 4
| -14.26% | -300.00 |
$15.00 | -$4,500.00 | 1.8K |
Scheduled
|
Apr 29
| ||
Form 4
| -4.54% | -100.00 |
$15.00 | -$1,500.00 | 2.1K |
Apr 27
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 12
| |||
Form 3/A
|
—
|
0
|
—
|
—
|
0
| ||||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Inmune Bio, Inc. (INMB) Snapshot price: $5.88
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 14
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 16
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 21
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 22
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 19
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 25
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
METABASIS THERAPEUTICS INC No price found
Sr. VP Business Development
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 29
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 4
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 2
| |||
Form 4
| -58.81% | -4.30K |
$8.21 | -$35,282.00 | 3.01K |
Scheduled
|
Apr 24
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 7
| |||
Form 4
| -8.74% | -700.00 |
$8.00 | -$5,600.00 | 7.31K |
Scheduled
|
Feb 26
| ||
Form 4
| -21.90% | -500.00 |
$8.35 | -$4,175.00 | 1.78K |
Scheduled
|
Jun 26
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 19
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 9
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 18
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||